Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
An effective vaccine requires the induction of broadly neutralising antibodies (bNAb). Generally, bNAbs emerge after years of virus-antibody co-evolution in infected individuals; they usually recognise conserved epitopes on densely glycosylated envelope glycoproteins (Env). The development of recombinant immunogens that closely resemble the natural trimeric conformation of Env, such as those designed on the basis of SOSIP, could accelerate the development of HIV-1 vaccines by triggering autologous NAb reactions in various animal models.Liposomes based on the natural flexible linkage (NFL) Env trimer of 16055; an evolved branching C virus isolate with a Tier-2 phenotype. These immunogens induce an autologous NAb response in rhesus monkeys and 16055 may be a suitable Env genotype.